Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

BUY
$2.93 - $4.19 $30,765 - $43,995
10,500 Added 27.27%
49,000 $163,000
Q3 2021

Nov 15, 2021

BUY
$3.17 - $4.61 $58,645 - $85,285
18,500 Added 92.5%
38,500 $126,000
Q2 2021

Aug 10, 2021

BUY
$3.71 - $5.18 $18,550 - $25,900
5,000 Added 33.33%
20,000 $93,000
Q1 2021

Sep 15, 2021

BUY
$2.96 - $9.4 $44,400 - $141,000
15,000 New
15,000 $65,000

Others Institutions Holding INVO

# of Institutions
1
Shares Held
14.1K
Call Options Held
0
Put Options Held
0

About INVO Bioscience, Inc.


  • Ticker INVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,169,700
  • Market Cap $8.76M
  • Description
  • INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More about INVO
Track This Portfolio

Track Connors Investor Services Inc Portfolio

Follow Connors Investor Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.